Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Asset Writedowns and Impairment (2020 - 2025)

Biofrontera (BFRI) has 6 years of Asset Writedowns and Impairment data on record, last reported at $13000.0 in Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment fell 61.76% year-over-year to $13000.0; the TTM value through Sep 2025 reached $7000.0, down 90.67%, while the annual FY2024 figure was $162000.0, 32.79% up from the prior year.
  • Asset Writedowns and Impairment reached $13000.0 in Q3 2025 per BFRI's latest filing, up from -$11000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $94000.0 in Q3 2023 and bottomed at -$46000.0 in Q1 2025.
  • Average Asset Writedowns and Impairment over 5 years is $20526.3, with a median of $13000.0 recorded in 2021.
  • The widest YoY moves for Asset Writedowns and Impairment: up 4650.0% in 2022, down 1550.0% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $13000.0 in 2021, then plummeted by 53.85% to $6000.0 in 2022, then crashed by 700.0% to -$36000.0 in 2023, then skyrocketed by 241.67% to $51000.0 in 2024, then tumbled by 74.51% to $13000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $13000.0 in Q3 2025, -$11000.0 in Q2 2025, and -$46000.0 in Q1 2025.